Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies
Clinical trial NCT01416428 · TERMINATED
Trial details
- NCT number
- NCT01416428
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-15
- Primary completion
- 2016-08-08
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.